Physician

Thomas E Gribbin, M.D.

According to 2025 Medicare claims, Thomas Gribbin, M.D. (NPI: 1639179286) practices hematology/oncology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (NPI: 1528018389; TIN: 382777354) and primary practice location at 49546-2379. Gribbin is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Gribbin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 274 traditional Medicare patients, billed 51,942 HCPCS/CPT codes, and received $1,214,403 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,846 prescription claims across 389 beneficiaries totaling $3,816,722 in drug costs, led by Calquence (Acalabrutinib Maleate). 2023 DME data shows 22 claims. Open Payments data shows 13 records totaling $285. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,051,735 and ending at $1,214,403. Concurrently, Part D prescription costs have risen steadily, from $2,244,731 to $3,816,722. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.